ULS ULS
Company Profile ↓Company Overview
ULS (ULS) is a publicly traded company listed on with a market capitalization of $15.89B. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Generates a return on equity of 25.8%, reflecting efficient use of shareholder capital.
Return on capital employed stands at 25.8%.
Operating margin of 18.2% supports profitability.
Generates positive free cash flow, funding growth and shareholder returns internally.
Recent Developments
- Dec 2025 Revenue of $3.05B (+6.4% YoY); net profit $325.00M.
- Trailing 12 Months Year-on-year growth — revenue +6.4%, earnings -0.3%.
- 5-Year Trend Long-term compounding — revenue CAGR 6.6%, profit CAGR 3.5%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 6.60% |
| 1 Year: | 6.38% |
Compounded Profit Growth
| 5 Years: | 3.52% |
| 1 Year: | -0.31% |
Stock Price Performance
| 1 Year: | +10.68% |
| 6 Months: | +12.29% |
| 3 Months: | -24.42% |
| 1 Month: | -10.59% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- Price vs 200-DMABelow
- RSI (14)31.14 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Strong return on equity of 25.8%.
- Healthy ROCE of 25.8%.
- Generates positive free cash flow.
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
No notable concerns flagged.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 629.00M | 689.00M | 676.00M | 670.00M | 730.00M | 731.00M | - | 705.00M | 776.00M | 783.00M | 789.00M | 758.00M |
| Cost of Revenue | - | - | - | - | - | - | - | 365.00M | 393.00M | 389.00M | 397.00M | 377.00M |
| Gross Profit | - | - | - | - | - | - | - | 340.00M | 383.00M | 394.00M | 392.00M | 381.00M |
| Operating Expenses | - | - | - | - | - | - | - | 232.00M | 244.00M | 238.00M | 239.00M | 243.00M |
| Operating Income | 75.00M | 117.00M | 89.00M | 91.00M | 126.00M | 130.00M | - | 108.00M | 139.00M | 156.00M | 153.00M | 138.00M |
| EBITDA | - | - | - | - | - | - | - | 151.00M | 181.00M | 202.00M | 165.00M | 184.00M |
| Interest Expense | - | - | - | - | - | - | - | 12.00M | 10.00M | 10.00M | 9.00M | 8.00M |
| Pretax Income | - | - | - | - | - | - | - | 94.00M | 125.00M | 146.00M | 105.00M | 129.00M |
| Tax Provision | - | - | - | - | - | - | - | 23.00M | 28.00M | 40.00M | 34.00M | 32.00M |
| Net Income | 55.00M | 94.00M | 53.00M | 56.00M | 101.00M | 88.00M | - | 67.00M | 91.00M | 100.00M | 67.00M | 92.00M |
| Diluted EPS | 0.28 | 0.47 | 0.27 | 0.28 | 0.50 | 0.44 | - | 0.33 | 0.45 | 0.49 | 0.32 | 0.45 |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Revenue | - | 2.52B | 2.68B | 2.87B | 3.05B |
| Cost of Revenue | - | 1.31B | 1.39B | 1.48B | 1.54B |
| Gross Profit | - | 1.21B | 1.28B | 1.39B | 1.51B |
| Operating Expenses | - | 795.00M | 875.00M | 931.00M | 953.00M |
| Operating Income | - | 412.00M | 409.00M | 461.00M | 557.00M |
| EBITDA | - | 535.00M | 535.00M | 642.00M | 699.00M |
| Interest Expense | - | 17.00M | 35.00M | 55.00M | 41.00M |
| Pretax Income | - | 383.00M | 346.00M | 415.00M | 470.00M |
| Tax Provision | - | 74.00M | 70.00M | 70.00M | 125.00M |
| Net Income | - | 293.00M | 260.00M | 326.00M | 325.00M |
| Diluted EPS | - | 1.47 | 1.30 | 1.62 | 1.60 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Total Assets | - | 2.72B | 2.74B | 2.80B | 2.92B |
| Current Assets | - | 998.00M | 953.00M | 921.00M | 1.00B |
| Cash & Equivalents | - | 322.00M | 315.00M | 298.00M | 295.00M |
| Inventory | - | - | - | - | - |
| Receivables | - | 376.00M | 362.00M | 380.00M | 422.00M |
| Total Liabilities | - | 1.64B | 2.06B | 1.87B | 1.63B |
| Current Liabilities | - | 694.00M | 709.00M | 740.00M | 760.00M |
| Long Term Debt | - | 499.00M | 904.00M | 692.00M | 491.00M |
| Total Debt | - | 660.00M | 1.06B | 935.00M | 683.00M |
| Total Equity | - | 1.05B | 654.00M | 904.00M | 1.26B |
| Shares Outstanding | - | 200.00M | 200.00M | 200.17M | 201.03M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | 372.00M | 467.00M | 524.00M | 600.00M |
| Investing Cash Flow | - | -238.00M | -175.00M | -234.00M | -204.00M |
| Financing Cash Flow | - | -1.12B | -294.00M | -284.00M | -396.00M |
| Capital Expenditure | - | -164.00M | -215.00M | -237.00M | -197.00M |
| Free Cash Flow | - | 208.00M | 252.00M | 287.00M | 403.00M |
| Net Change in Cash | 371.00M | -982.00M | -2.00M | 6.00M | - |
Ratios (Annual)
Figures in %.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Gross Margin % | - | 47.9% | 47.9% | 48.5% | 49.5% |
| Operating Margin % | - | 16.3% | 15.3% | 16.1% | 18.2% |
| Net Margin % | - | 11.6% | 9.7% | 11.4% | 10.6% |
| ROE % | - | 27.8% | 39.8% | 36.1% | 25.8% |
| ROCE % | - | 20.3% | 20.2% | 22.4% | 25.8% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for ULS
Lakeland Fire + Safety Announces UL Certification of Veridian Wildland Glove to NFPA 1950 Standard
Certification Expands Lakeland’s Protective Glove Offering for Wildland and Urban Interface Firefighters HUNTSVILLE, Ala., Aug. 05, 2026 (GLOBE NEWSWIRE) -- Lakeland Industries, Inc. ("Lakeland Fire + Safety" or "Lakeland") (NASDAQ: LAKE), …
Is UL Solutions (ULS) Stock A Bargain Or Fully Priced?
UL Solutions stock has delivered a 22.0% gain over the past year, yet the current checks suggest it no longer looks obviously cheap, with the market price sitting close to its Discounted Cash Flow (DCF) based intrinsic value while earnings …
UL Solutions Inc. (ULS) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
Although the revenue and EPS for UL Solutions Inc. (ULS) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbe…
UL Solutions Inc. (ULS) Q2 Earnings and Revenues Top Estimates
UL Solutions Inc. (ULS) delivered earnings and revenue surprises of +5.36% and +0.51%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
UL Solutions’s (NYSE:ULS) Q2 CY2026 Earnings Results: Revenue In Line With Expectations
Safety certification company UL Solutions (NYSE:ULS) met Wall Street’s revenue expectations in Q2 CY2026, with sales up 5.2% year on year to $816 million. Its non-GAAP profit of $0.59 per share was 5.4% above analysts’ consensus estimates.…
UL Solutions Inc. Reports Strong Second Quarter 2026 Results
NORTHBROOK, Ill., August 04, 2026--UL Solutions Inc. (NYSE: ULS), a global leader in applied safety science, today reported results for the second quarter ended June 30, 2026.
ULS — Frequently Asked Questions
What is the current share price of ULS?
As of 2026-08-05 17:25 PDT, ULS trades at $79.05 on NASDAQ/NYSE. Its 52-week range is $62.21 to $104.74.
What is the market capitalisation of ULS?
ULS has a market capitalisation of $15.89B on NASDAQ/NYSE.
What is the P/E ratio of ULS?
ULS trades at a trailing price-to-earnings (P/E) ratio of 49.41. Its price-to-book (P/B) ratio is 12.59.
What is the return on equity (ROE) of ULS?
ULS has a return on equity (ROE) of 25.75%. Its return on capital employed (ROCE) is 25.78%.
Is ULS a good stock to buy?
This page provides a data-driven analysis of ULS, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.